ELIXF (Elixxer) Cyclically Adjusted Book per Share: $0.77 (As of Dec. 2025)


What is Elixxer Cyclically Adjusted Book per Share?

Elixxer ELIXF Cyclically Adjusted Book per Share is $0.77 as of Dec. 2025. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Elixxer's adjusted book value per share for the three months ended in Dec. 2025 was $-0.643. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.77 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Elixxer's average Cyclically Adjusted Book Growth Rate was -9.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -4.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -0.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Elixxer was 54.80% per year. The lowest was -11.30% per year. And the median was 3.90% per year.

As of today (2026-06-27), Elixxer's current stock price is $0.0335. Elixxer's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was $0.77. Elixxer's Cyclically Adjusted PB Ratio of today is 0.04.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Elixxer was 163.04. The lowest was 0.01. And the median was 1.01.


Elixxer  (OTCPK:ELIXF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Elixxer's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.0335/0.77
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Elixxer was 163.04. The lowest was 0.01. And the median was 1.01.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Elixxer Cyclically Adjusted Book per Share Related Terms


Elixxer Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Elixxer's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixxer Cyclically Adjusted Book per Share Chart

Elixxer Annual Data
Trend Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.12 1.09 0.02 0.01 0.77

Elixxer Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.00 1.54 0.77

ELIXF vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Elixxer's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixxer Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixxer's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Elixxer's Cyclically Adjusted PB Ratio falls into.



Elixxer Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Elixxer's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.643/130.3661*130.3661
=-0.643

Current CPI (Dec. 2025) = 130.3661.

Elixxer Quarterly Data

Book Value per Share CPI Adj_Book
201509 0.865 100.421 1.123
201512 0.742 99.947 0.968
201603 0.703 101.054 0.907
201606 0.019 102.002 0.024
201609 2.462 101.765 3.154
201612 1.586 101.449 2.038
201703 1.725 102.634 2.191
201706 1.287 103.029 1.628
201709 0.486 103.345 0.613
201712 1.516 103.345 1.912
201803 4.266 105.004 5.296
201806 3.915 105.557 4.835
201809 3.566 105.636 4.401
201812 3.565 105.399 4.409
201903 3.122 106.979 3.805
201906 3.408 107.690 4.126
202003 1.431 107.927 1.729
202006 1.319 108.401 1.586
202009 1.389 108.164 1.674
202012 0.586 108.559 0.704
202103 0.848 110.298 1.002
202106 1.347 111.720 1.572
202109 0.683 112.905 0.789
202112 0.589 113.774 0.675
202203 0.346 117.646 0.383
202206 -0.173 120.806 -0.187
202209 -0.163 120.648 -0.176
202212 -0.363 120.964 -0.391
202303 -0.421 122.702 -0.447
202306 -0.503 124.203 -0.528
202309 -0.559 125.230 -0.582
202312 -0.631 125.072 -0.658
202403 -0.675 126.258 -0.697
202406 -0.707 127.522 -0.723
202409 -0.750 127.285 -0.768
202412 -0.810 127.364 -0.829
202503 -0.839 129.181 -0.847
202506 -0.921 129.892 -0.924
202509 -0.959 130.287 -0.960
202512 -0.643 130.366 -0.643

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.77 mean?
Elixxer (ELIXF) has a Cyclically Adjusted Book per Share of $0.77 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Elixxer and its competitors.
Is Elixxer's Cyclically Adjusted Book per Share too high?
Elixxer's current Cyclically Adjusted Book per Share is $0.77.
How does Elixxer's Cyclically Adjusted Book per Share compare to ZTS?
Elixxer's Cyclically Adjusted Book per Share of $0.77 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Elixxer and its competitors. Elixxer's current Cyclically Adjusted Book per Share is $0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixxer stock overvalued right now?
Elixxer (ELIXF) has a current Cyclically Adjusted Book per Share of $0.77. The current Cyclically Adjusted Book per Share is $0.77. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Elixxer (ELIXF), the current Cyclically Adjusted Book per Share is $0.77 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elixxer Business Description

Other Exchanges ELXR.H:Canada
Address 200 Bay Street, Suite 3240, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.